Encouragingly, a variety of targeted therapies, including vascular endothelial growth factor (VEGF),22 hepatocyte growth factor,23 and fibroblast growth factor receptor 4 (FGFR4),24 have been approved as promising treatments for advanced HCC. Here, FGFR4 is linked to hepatocellular carcinoma.